Clinical and endoscopic characteristics of non‐Helicobacter pylori, non‐NSAID duodenal ulcers: a long‐term prospective study
- 27 December 2001
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (12) , 1875-1882
- https://doi.org/10.1046/j.1365-2036.2001.01115.x
Abstract
The proportion of duodenal ulcers not associated with Helicobacter pylori infection or the use of non-steroidal anti-inflammatory drugs (NSAIDs) is increasing. To identify the clinical and endoscopic characteristics of non-H. pylori, non-NSAID duodenal ulcers. Clinical and endoscopic data and H. pylori status were prospectively collected from consecutive patients who underwent upper endoscopy from 1997 to 1999. Patients with duodenal ulcers were identified, and those with non-H. pylori, non-NSAID duodenal ulcers were analysed further. A total of 11 717 upper endoscopies were performed in 8344 patients. Of these, 1153 (14%) had duodenal ulcers. Of 599 patients with active ulcers and known H. pylori status, 104 (17%) had ulcers not associated with H. pylori or the use of NSAIDs, 393 (66%) had ulcers associated with H. pylori alone, 51 (8.5%) had ulcers associated with the use of NSAIDs alone and 51 (8.5%) had ulcers associated with both. Multivariate logistic regression analysis revealed that the presence of concomitant diseases (odds ratio=15.0; 95% confidence interval, 8.64–25.9; P < 0.001) and the absence of epigastric pain/discomfort (odds ratio=0.52; 95% confidence interval, 0.29–0.91; P=0.022) were independent predictors for non-H. pylori, non-NSAID duodenal ulcers. Non-H. pylori, non-NSAID duodenal ulcers exhibit certain distinct clinical and endoscopic characteristics. The presence of concomitant diseases is an important predictive factor.Keywords
This publication has 30 references indexed in Scilit:
- Diet and duodenal ulcerDigestive and Liver Disease, 2000
- Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?Alimentary Pharmacology & Therapeutics, 2000
- Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect often years of H. pylori treatment?Australian and New Zealand Journal of Medicine, 1998
- Leading Article: Leading Article Anti-infectives: Prospects for improved therapy forHelicobacter pyloriinfectionExpert Opinion on Investigational Drugs, 1996
- Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.Gut, 1995
- The Epidemiology of Peptic Ulcer Mortality 1953–1989: A Birth Cohort AnalysisInternational Journal of Epidemiology, 1993
- Life Events and Daily Stress in Duodenal Ulcer DiseaseDigestion, 1992
- Pathogenetic role ofHelicobacter pylori in duodenal ulcer diseaseDigestive Diseases and Sciences, 1991
- Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonistAlimentary Pharmacology & Therapeutics, 1989
- Persistence ofCampylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritisDigestive Diseases and Sciences, 1987